CA2461360A1 - Thiazoles 3-pyridyle ou 4-isoquinolinyle utilises comme inhibiteurs de lyase c17,20 - Google Patents
Thiazoles 3-pyridyle ou 4-isoquinolinyle utilises comme inhibiteurs de lyase c17,20 Download PDFInfo
- Publication number
- CA2461360A1 CA2461360A1 CA002461360A CA2461360A CA2461360A1 CA 2461360 A1 CA2461360 A1 CA 2461360A1 CA 002461360 A CA002461360 A CA 002461360A CA 2461360 A CA2461360 A CA 2461360A CA 2461360 A1 CA2461360 A1 CA 2461360A1
- Authority
- CA
- Canada
- Prior art keywords
- pyridyl
- thiazole
- bond
- etoac
- cndot
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Communicable Diseases (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
La présente invention concerne de nouveaux thiazoles portant des substituants 3-pyridyle ou 4-isoquinilinyle et des compositions pharmaceutiques de ceux-ci. Cette invention concerne aussi des techniques d'utilisation de ces composés et des compositions pharmaceutiques de cette invention utilisés comme inhibiteurs de lyases, par exemple de l'enzyme 17a-hydroxylase C17,20. Cette invention concerne enfin des techniques de traitement du cancer d'un patient qui consiste à administrer à ce patient un composé de l'invention ou une composition pharmaceutique de ces composés. Il peut s'agir d'un cancer de la prostate ou d'un cancer du sein, par exemple.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32499301P | 2001-09-26 | 2001-09-26 | |
US60/324,993 | 2001-09-26 | ||
PCT/US2002/030483 WO2003027085A2 (fr) | 2001-09-26 | 2002-09-26 | Thiazoles 3-pyridyle ou 4-isoquinolinyle utilises comme inhibiteurs de lyase c17,20 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2461360A1 true CA2461360A1 (fr) | 2003-04-03 |
Family
ID=23265979
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002461363A Abandoned CA2461363A1 (fr) | 2001-09-26 | 2002-09-26 | 3-pyridyl indoles et indazoles substitues servant d'inhibiteurs de c17,20 lyase |
CA002461360A Abandoned CA2461360A1 (fr) | 2001-09-26 | 2002-09-26 | Thiazoles 3-pyridyle ou 4-isoquinolinyle utilises comme inhibiteurs de lyase c17,20 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002461363A Abandoned CA2461363A1 (fr) | 2001-09-26 | 2002-09-26 | 3-pyridyl indoles et indazoles substitues servant d'inhibiteurs de c17,20 lyase |
Country Status (5)
Country | Link |
---|---|
EP (2) | EP1432706A2 (fr) |
JP (2) | JP2005532983A (fr) |
AU (2) | AU2002340010A1 (fr) |
CA (2) | CA2461363A1 (fr) |
WO (8) | WO2003027094A2 (fr) |
Families Citing this family (76)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4160295B2 (ja) * | 2000-12-08 | 2008-10-01 | 武田薬品工業株式会社 | 3−ピリジル基を有する置換チアゾール誘導体、その製造法および用途 |
CA2431171A1 (fr) * | 2000-12-08 | 2002-06-13 | Takeda Chemical Industries, Ltd. | Derives thiazole substitues porteurs de groupes 3-pyridyl, procede d'elaboration et leur utilisation |
US20040147561A1 (en) * | 2002-12-27 | 2004-07-29 | Wenge Zhong | Pyrid-2-one derivatives and methods of use |
US7244739B2 (en) * | 2003-05-14 | 2007-07-17 | Torreypines Therapeutics, Inc. | Compounds and uses thereof in modulating amyloid beta |
ES2222827B1 (es) * | 2003-07-30 | 2006-03-01 | Laboratorios Del Dr. Esteve, S.A. | Derivados de 5-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos. |
CN101675928A (zh) * | 2003-11-14 | 2010-03-24 | 沃泰克斯药物股份有限公司 | 可用作atp-结合弹夹转运蛋白调控剂的噻唑和噁唑 |
AU2005232745A1 (en) | 2004-04-13 | 2005-10-27 | Astellas Pharma Inc. | Polycyclic pyrimidines as potassium ion channel modulators |
JP4602686B2 (ja) * | 2004-04-15 | 2010-12-22 | 広栄化学工業株式会社 | 2,6−ジハロゲノ−4−アリールピリジン類の製造法 |
EP1815206B1 (fr) | 2004-10-13 | 2016-04-06 | PTC Therapeutics, Inc. | Composes de suppression de non-sens et procedes de leur utilisation |
DK1802579T3 (da) * | 2004-10-20 | 2014-01-20 | Merck Serono Sa | Derivater af 3-arylaminopyridin |
WO2006051723A1 (fr) * | 2004-11-09 | 2006-05-18 | Kaneka Corporation | Méthode de synthèse de 1-halogéno-3-aryl-2-propanone |
GB0428514D0 (en) * | 2004-12-31 | 2005-02-09 | Prosidion Ltd | Compounds |
CN101142185A (zh) * | 2005-01-19 | 2008-03-12 | 比奥里波克斯公司 | 用于炎症治疗的吲哚 |
US8088806B2 (en) | 2005-05-09 | 2012-01-03 | Achillion Pharmaceuticals, Inc. | Thiazole compounds and methods of use |
CN101233119A (zh) * | 2005-07-29 | 2008-07-30 | 4Sc股份有限公司 | 新型杂环NF-κB抑制剂 |
FR2889526B1 (fr) | 2005-08-04 | 2012-02-17 | Aventis Pharma Sa | 7-aza-indazoles substitues, compositions les contenant, procede de fabrication et utilisation |
US7947707B2 (en) * | 2005-10-07 | 2011-05-24 | Kissei Pharmaceutical Co., Ltd. | Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
TWI385169B (zh) | 2005-10-31 | 2013-02-11 | Eisai R&D Man Co Ltd | 經雜環取代之吡啶衍生物及含有彼之抗真菌劑 |
JP2009523701A (ja) * | 2005-12-28 | 2009-06-25 | 武田薬品工業株式会社 | 縮合複素環化合物およびその用途 |
WO2007082808A2 (fr) * | 2006-01-18 | 2007-07-26 | F. Hoffmann-La Roche Ag | Thiazoles en tant qu'inhibiteurs de 11 beta-hsd1 |
BRPI0706411A2 (pt) * | 2006-01-24 | 2011-03-29 | Lilly Co Eli | composto, composição farmacêutica, método de preparação de um indol ou um sal farmaceuticamente aceitável do mesmo, e, uso de um composto |
PT2001849E (pt) | 2006-03-29 | 2015-02-05 | Hoffmann La Roche | Derivados de piridina e pirimidina como antagonistas de r2mglu |
US7652018B2 (en) | 2006-08-15 | 2010-01-26 | Wyeth Llc | Imidazolidin-2-one derivatives useful as PR modulators |
WO2008021337A1 (fr) | 2006-08-15 | 2008-02-21 | Wyeth | Dérivés oxazinan-2-one utiles comme modulateurs pr |
WO2008021338A2 (fr) | 2006-08-15 | 2008-02-21 | Wyeth | Dérivés d'oxazolidone tricycliques utiles en tant que modulateurs du récepteur de la progestérone |
US7649007B2 (en) | 2006-08-15 | 2010-01-19 | Wyeth Llc | Oxazolidine derivatives as PR modulators |
ATE534642T1 (de) * | 2006-09-21 | 2011-12-15 | Eisai R&D Man Co Ltd | Durch einen heteroarylring substituiertes pyridinderivat und antipilzmittel, das dieses enthält |
EP2065377B1 (fr) | 2006-09-21 | 2011-11-23 | Eisai R&D Management Co., Ltd. | Dérivé de pyridine substitué par un cycle hétéroaryle, et agent antifongique le comprenant |
WO2008042898A2 (fr) | 2006-10-02 | 2008-04-10 | Cortendo Invest, Ab | Énantiomère de cétoconazole chez les êtres humains |
US8466154B2 (en) | 2006-10-27 | 2013-06-18 | The Board Of Regents Of The University Of Texas System | Methods and compositions related to wrapping of dehydrons |
US9187485B2 (en) | 2007-02-02 | 2015-11-17 | Baylor College Of Medicine | Methods and compositions for the treatment of cancer and related hyperproliferative disorders |
CN101801964A (zh) | 2007-05-22 | 2010-08-11 | 艾其林医药公司 | 杂芳基取代的噻唑及其作为抗病毒剂的用途 |
CA2699980C (fr) | 2007-08-13 | 2015-06-02 | Divergence, Inc. | Compositions et procedes pour lutter contre les nematodes |
BRPI0818658A2 (pt) | 2007-10-09 | 2015-04-14 | Merck Patent Ges Mit Beschränkter Haftung | Derivados de piridina úteis como ativadores de glicoquinase |
US8513287B2 (en) | 2007-12-27 | 2013-08-20 | Eisai R&D Management Co., Ltd. | Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same |
BRPI0906838A2 (pt) | 2008-01-11 | 2015-07-14 | Novartis Ag | Pirimidinas como inibidores de quinase |
WO2009094224A1 (fr) | 2008-01-25 | 2009-07-30 | Millennium Pharmaceuticals, Inc. | Thiophènes et leurs utilisations |
ES2655305T3 (es) | 2008-02-08 | 2018-02-19 | Shiseido Company, Ltd. | Agente para blanqueamiento de la piel |
US9447049B2 (en) | 2010-03-01 | 2016-09-20 | University Of Tennessee Research Foundation | Compounds for treatment of cancer |
US9029408B2 (en) | 2008-06-16 | 2015-05-12 | Gtx, Inc. | Compounds for treatment of cancer |
DK2959900T3 (en) | 2008-06-16 | 2017-06-26 | Univ Tennessee Res Found | CONNECTION TO TREATMENT OF CANCER |
US8822513B2 (en) | 2010-03-01 | 2014-09-02 | Gtx, Inc. | Compounds for treatment of cancer |
AU2009282567B2 (en) * | 2008-08-20 | 2014-10-02 | Merck Sharp & Dohme Corp. | Substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
US8536185B2 (en) | 2008-09-22 | 2013-09-17 | Cayman Chemical Company, Incorporated | Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases |
US9090601B2 (en) | 2009-01-30 | 2015-07-28 | Millennium Pharmaceuticals, Inc. | Thiazole derivatives |
CN102395585A (zh) | 2009-01-30 | 2012-03-28 | 米伦纽姆医药公司 | 杂芳基化合物和其作为pi3k抑制剂的用途 |
US8796314B2 (en) | 2009-01-30 | 2014-08-05 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
WO2010106290A1 (fr) * | 2009-03-19 | 2010-09-23 | Sanofi-Aventis | Derives d'indazole inhibiteurs d'hsp90, compositions les contenant et utilisation |
EP2592071B1 (fr) * | 2009-10-29 | 2019-09-18 | Bristol-Myers Squibb Company | Composés hétérocycliques tricycliques |
WO2011051198A2 (fr) * | 2009-10-30 | 2011-05-05 | Bayer Cropscience Ag | Dérivés de pyridine en tant qu'agents phytoprotecteurs |
DE102009058280A1 (de) * | 2009-12-14 | 2011-06-16 | Merck Patent Gmbh | Thiazolderivate |
EP3064204A1 (fr) | 2010-03-01 | 2016-09-07 | GTx, Inc. | Composes pour le traitement du cancer |
CN103140490A (zh) | 2010-07-15 | 2013-06-05 | 百时美施贵宝公司 | 氮杂吲唑化合物 |
AU2011285724B2 (en) | 2010-08-04 | 2015-01-22 | Pellficure Pharmaceuticals, Inc. | Combination therapy for the treatment of prostate carcinoma |
US9062038B2 (en) | 2010-08-11 | 2015-06-23 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
EP2603216A4 (fr) | 2010-08-11 | 2013-12-18 | Millennium Pharm Inc | Hétéroaryles et utilisations |
CN103153300A (zh) | 2010-08-11 | 2013-06-12 | 米伦纽姆医药公司 | 杂芳基化合物和其用途 |
SG189396A1 (en) | 2010-10-13 | 2013-05-31 | Millennium Pharm Inc | Heteroaryls and uses thereof |
CN103270029B (zh) * | 2010-10-22 | 2016-01-20 | 拜耳知识产权有限责任公司 | 作为农药的杂环化合物 |
CA2816088A1 (fr) * | 2010-10-28 | 2012-05-03 | Viamet Pharmaceuticals, Inc. | Composes inhibiteurs de metalloenzymes |
EP2638041B1 (fr) | 2010-11-12 | 2015-07-22 | Bristol-Myers Squibb Company | Dérivés azaindole substitués |
GB2485404A (en) * | 2010-11-15 | 2012-05-16 | Nat Univ Ireland | Metal-complexed pyridyl-substituted tetrazole compounds and their use in treating cancer |
CN102675286B (zh) * | 2011-03-07 | 2015-08-19 | 中国科学院上海药物研究所 | 一类吲唑类化合物及其制备方法、用途和药物组合物 |
CN103649073B (zh) | 2011-04-28 | 2016-04-13 | 诺瓦提斯公司 | 17α-羟化酶/C17,20-裂合酶抑制剂 |
WO2012162468A1 (fr) * | 2011-05-25 | 2012-11-29 | Janssen Pharmaceutica Nv | Dérivés de thiazole en tant qu'inhibiteurs de pro-métalloprotéinases de matrice |
EP2760870B1 (fr) | 2011-09-27 | 2016-05-04 | Bristol-Myers Squibb Company | Composés d'hétéroaryle bicycliques substitués |
WO2014055595A1 (fr) | 2012-10-05 | 2014-04-10 | Merck Sharp & Dohme Corp. | Composés d'indoline utilisés comme inhibiteurs de l'aldostérone synthase et applications s'y rapportant |
EP2934144B1 (fr) | 2012-12-20 | 2017-07-19 | Merck Sharp & Dohme Corp. | Composés d'indazole utiles comme inhibiteurs de l'aldostérone synthase |
CN109568312A (zh) | 2013-03-05 | 2019-04-05 | 田纳西大学研究基金会 | 用于治疗癌症的化合物 |
EP2968219B1 (fr) | 2013-03-14 | 2019-04-24 | Pellficure Pharmaceuticals, Inc. | Nouvelle thérapie pour le carcinome de la prostate |
CA2960750A1 (fr) | 2014-09-12 | 2016-03-17 | Pellficure Pharmaceuticals, Inc. | Compositions et methodes de traitement d'un carcinome de la prostate |
CA3044812A1 (fr) | 2016-10-24 | 2018-05-03 | Pellficure Pharmaceuticals Inc. | Compositions pharmaceutiques de 5-hydroxy-2-methylnaphtalene-1, 4-dione |
JP7193071B2 (ja) * | 2017-02-08 | 2022-12-20 | 国立大学法人東海国立大学機構 | 蛍光発光材料および紫外線吸収剤 |
CN115087657A (zh) * | 2019-12-18 | 2022-09-20 | 加利福尼亚大学董事会 | Lin28抑制剂和其使用方法 |
US20210246109A1 (en) * | 2020-02-11 | 2021-08-12 | University Of Kentucky Research Foundation | Potent and selective inhibitors of cytochrome p450 |
WO2023049199A1 (fr) * | 2021-09-24 | 2023-03-30 | Zeno Management, Inc. | Composés azole |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK150068C (da) * | 1978-06-02 | 1987-06-29 | Pfizer | Analogifremgangsmaade til fremstilling af aminothiazoler |
JPS55133366A (en) * | 1979-04-05 | 1980-10-17 | Otsuka Pharmaceut Factory Inc | Thiazole derivative |
US4536505A (en) * | 1983-05-17 | 1985-08-20 | Ciba-Geigy Corporation | Certain N-(pyridyl) indoles |
DE3940476A1 (de) * | 1989-12-07 | 1991-06-13 | Bayer Ag | Pyridinylpyrimidin-derivate |
DE3940477A1 (de) * | 1989-12-07 | 1991-06-13 | Bayer Ag | Hetaryl-substituierte pyridinylpyrimidin-derivate |
JPH04154773A (ja) * | 1990-10-15 | 1992-05-27 | Green Cross Corp:The | チアゾール誘導体 |
DE4117560A1 (de) * | 1991-05-29 | 1992-12-03 | Bayer Ag | Verwendung von pyridinylpyrimidin-derivaten zum schutz technischer materialien |
TW223004B (fr) * | 1991-11-25 | 1994-05-01 | Sumitomo Chemical Co | |
US5599774A (en) * | 1992-01-22 | 1997-02-04 | Imperial Chemical Industries Plc | N-arylindoles and their use as herbicides |
US5395817A (en) * | 1992-01-22 | 1995-03-07 | Imperial Chemical Industries Plc | N-arylindoles and their use as herbicides |
AU665818B2 (en) * | 1992-03-09 | 1996-01-18 | Zeneca Limited | Novel arylindazoles and their use as herbicides |
US5444038A (en) * | 1992-03-09 | 1995-08-22 | Zeneca Limited | Arylindazoles and their use as herbicides |
EP0790057B1 (fr) * | 1994-11-29 | 2002-06-05 | Hisamitsu Pharmaceutical Co., Inc. | Antibacterien et bactericide comprenant un derive de 2-aminothiazole et sels de ce derive |
US6046136A (en) * | 1997-06-24 | 2000-04-04 | Zeneca Limited | Herbicidal heterocyclic N-oxides compounds |
US5840721A (en) * | 1997-07-09 | 1998-11-24 | Ontogen Corporation | Imidazole derivatives as MDR modulators |
AU732406B2 (en) * | 1997-10-03 | 2001-04-26 | Merck Frosst Canada & Co. | Aryl thiophene derivatives as PDE IV inhibitors |
CA2331118A1 (fr) * | 1998-05-12 | 1999-11-18 | Wyeth | Acides oxazol-aryl-carboxyliques utiles dans le traitement de l'insulinoresistance et de l'hyperglycemie |
AU5227999A (en) * | 1998-07-27 | 2000-02-21 | Abbott Laboratories | Substituted oxazolines as antiproliferative agents |
ES2317889T3 (es) * | 2000-03-01 | 2009-05-01 | Janssen Pharmaceutica Nv | Derivados de tiazolilo 2,4-disustituido. |
-
2002
- 2002-09-26 WO PCT/US2002/030482 patent/WO2003027094A2/fr not_active Application Discontinuation
- 2002-09-26 WO PCT/US2002/030924 patent/WO2003027100A1/fr not_active Application Discontinuation
- 2002-09-26 JP JP2003530675A patent/JP2005532983A/ja not_active Withdrawn
- 2002-09-26 WO PCT/US2002/030979 patent/WO2003027101A1/fr not_active Application Discontinuation
- 2002-09-26 WO PCT/US2002/030483 patent/WO2003027085A2/fr not_active Application Discontinuation
- 2002-09-26 WO PCT/US2002/030983 patent/WO2003027096A1/fr not_active Application Discontinuation
- 2002-09-26 EP EP02799636A patent/EP1432706A2/fr not_active Withdrawn
- 2002-09-26 WO PCT/US2002/030834 patent/WO2003027107A1/fr not_active Application Discontinuation
- 2002-09-26 CA CA002461363A patent/CA2461363A1/fr not_active Abandoned
- 2002-09-26 JP JP2003530682A patent/JP2005528325A/ja not_active Withdrawn
- 2002-09-26 WO PCT/US2002/030982 patent/WO2003027095A1/fr not_active Application Discontinuation
- 2002-09-26 AU AU2002340010A patent/AU2002340010A1/en not_active Abandoned
- 2002-09-26 CA CA002461360A patent/CA2461360A1/fr not_active Abandoned
- 2002-09-26 AU AU2002362603A patent/AU2002362603A1/en not_active Abandoned
- 2002-09-26 EP EP02778338A patent/EP1432698A2/fr not_active Withdrawn
- 2002-09-26 WO PCT/US2002/030981 patent/WO2003027105A1/fr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2003027096A1 (fr) | 2003-04-03 |
EP1432706A2 (fr) | 2004-06-30 |
JP2005528325A (ja) | 2005-09-22 |
WO2003027095A1 (fr) | 2003-04-03 |
CA2461363A1 (fr) | 2003-04-03 |
JP2005532983A (ja) | 2005-11-04 |
AU2002340010A1 (en) | 2003-04-07 |
WO2003027094A2 (fr) | 2003-04-03 |
EP1432698A2 (fr) | 2004-06-30 |
WO2003027105A1 (fr) | 2003-04-03 |
WO2003027094A3 (fr) | 2003-10-23 |
WO2003027085A3 (fr) | 2003-12-04 |
WO2003027101A1 (fr) | 2003-04-03 |
WO2003027100A1 (fr) | 2003-04-03 |
WO2003027107A1 (fr) | 2003-04-03 |
WO2003027085A2 (fr) | 2003-04-03 |
AU2002362603A1 (en) | 2003-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2461360A1 (fr) | Thiazoles 3-pyridyle ou 4-isoquinolinyle utilises comme inhibiteurs de lyase c17,20 | |
US20040198773A1 (en) | Substituted 3-pyridyl oxazoles as c17,20 lyase inhibitors | |
US20040267017A1 (en) | 3-pyridyl or 4-isoquinolinyl thiazoles as c17, 20 lyase inhibitors | |
EP1751146B1 (fr) | Pyridinyl-ou pyrimidinyl thiazoles ayant une activite inhibitrice des proteines kinases | |
AU2007237904B2 (en) | 6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling | |
CN109761976B (zh) | 八氢稠合的氮杂萘烷糖皮质激素受体调节剂 | |
JP5074653B2 (ja) | 2−置換4−ヘテロアリール−ピリミジンおよび増殖性障害におけるその使用 | |
AU2006290814B2 (en) | 2-aniline-4-aryl substituted thiazole derivatives | |
CA2872260C (fr) | Modulateurs des recepteurs de glucocorticoides consistant en azadecalines a heteroaryle cetone fusionne | |
JP5363315B2 (ja) | 新規ピペラジン、医薬組成物、およびその使用方法 | |
WO2010001169A2 (fr) | Composés chimiques 251 | |
AU2005270102A1 (en) | Compounds useful for inhibiting Chk1 | |
KR102214222B1 (ko) | 신규 pde4 저해제 | |
KR20090026187A (ko) | 티로신 키나제 억제제 | |
US20040236110A1 (en) | Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors | |
KR20140027907A (ko) | 치환된 벤즈아미드 및 그의 용도 | |
JP6130383B2 (ja) | ピリジン誘導体 | |
AU2013245809A1 (en) | Substituted benzamides and their uses | |
EP2760870B1 (fr) | Composés d'hétéroaryle bicycliques substitués | |
US20040209924A1 (en) | Substituted 3-pyridyl imidazoles as c17,20 lyase inhibitors | |
JP2004516322A (ja) | ファルネシルトランスフェラーゼを阻害する4−ヘテロシクリル−キノリンおよびキナゾリン誘導体 | |
EP1814554A1 (fr) | Composes, compositions et methodes | |
JPS59167586A (ja) | チオフエン誘導体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |